Home › Cancer (all types) › Utah
Cancer (all types) clinical trials in Utah
40 studies for Cancer (all types) are looking for participants at sites in Utah.
Cities in Utah
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- South Jordan Health Center, South Jordan
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05256225A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Sep 25, 2026 · NCT07630974SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07410689A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Cedar City Hospital, SW Cancer Clinic, Sandra Maxwell Cancer Center, Cedar City
- Intermountain Healthcare, Salt Lake City
- Dixie Regional Medical Center-River Road Campus, St. George
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
RecruitingPhase 2/3
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Sep 17, 2026 · NCT06941272(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cedar Clinical Research Inc., Draper
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06953960A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589A Phase 1/1b Study of IAM1363 in HER2 Cancers
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Community Cancer Trials of Utah, Ogden
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07169851Project: Every Child for Younger Patients With Cancer
- Primary Children's Hospital, Salt Lake City
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- START Mountain Region ( Site 1106), West Valley City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07209111Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05335928A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Aug 20, 2026 · NCT06678659Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
- Site 02, West Valley City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07276373A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06880549Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- South Jordan Health Center, South Jordan
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT06892522A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- START Mountain Region, LLC., West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT07556380First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06431594Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Recruiting
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572Galleri® in the Medicare Population.
- HCA Healthcare St. Marks, Salt Lake City
RecruitingHealthy volunteers welcome
Ages 50 and older · All sexes · Updated May 22, 2026 · NCT05673018Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
Recruiting
Ages 15 to 29 · All sexes · Updated May 22, 2026 · NCT05958316A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- GSK Investigational Site, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06551142I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT06132503Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734Improving Health Insurance Literacy Among Young Adult Cancer Survivors
- Intermountain Health, Murray
- University of Utah, Salt Lake City
Recruiting
Ages 26 to 45 · All sexes · Updated Apr 28, 2026 · NCT05829070CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
- Huntsman Cancer Institute, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Nov 26, 2025 · NCT06484179Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2025 · NCT05661461Childhood Cancer Predisposition Study (CCPS)
- Primary Children's Hospital, Salt Lake City
RecruitingObservational study
All ages · All sexes · Updated Oct 29, 2025 · NCT04511806SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Utah Cancer Specialists, Salt Lake City
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 6, 2025 · NCT05234177Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Intermountain Medical Center, Murray
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.